key: cord-0702083-vokj6ebk
authors: Agarwal, Pinky; Ray, Sudeshna; Madan, Arina; Tyson, Brad
title: Neurological manifestations in 404 COVID-19 patients in Washington State
date: 2020-08-06
journal: J Neurol
DOI: 10.1007/s00415-020-10087-z
sha: d189c77a88cded1f418a39c68462c4da789beb2c
doc_id: 702083
cord_uid: vokj6ebk

nan

We report neurological manifestations in 404 consecutive patients with COVID-19 seen in outpatient clinics and hospitalized between February 20, 2020 and May 4, 2020 at Evergreen Hospital, Kirkland, Washington, USA. This hospital was among the first to report cases and deaths of COVID-19 patients in the United States. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Most neurological manifestations of COVID-19 have been reported from non-USA health systems for hospitalized patients [1] [2] [3] .

All patients had laboratory confirmed SARS-CoV-2 infection. Only new onset neurological manifestations were included. Study data were extracted from electronic medical records, and all neurological manifestations were confirmed via chart review by a neurologist and neuropsychologist. The study was approved by institutional review board and ethics committee. Core presenting symptoms were fever, cough, and shortness of breath.

Clinical characteristics and admission laboratory measures are summarized in Table 1 . Shapiro's test revealed significant deviations from normal distribution. Therefore, non-parametric alternatives to the t test (Wilcox rank sum test and Hodges-Lehmann estimation) were used, at alpha level of 0.05, adjusted for multiple comparisons using the Benjamini-Hochberg method.

Female patients younger than 65 years old were more likely to have neurological symptoms; however, the findings were not statistically significant. Asian patients were 2.02 times more likely to have neurological symptoms than Caucasian patients, but the findings did not meet statistical significance either.

Frequencies of neurological symptoms are summarized in Table 2 . Neurological findings were reported in 295 of 404 (73.0%) patients, which is higher than reported by the previous studies from China and Spain [1, 3] . Mao Acute neurological manifestations were seen in 99 of 404 (24.5%) COVID-19 patients with altered mental status seen in 86 (21.3%), critical illness myopathy in 8 (2.0%), stroke including one hemorrhagic stroke in 3 (0.7%), and seizures in 2 (0.5%). Six patients had multiple acute neurological manifestations.

This study is useful to inform clinicians treating COVID-19 patients about neurological manifestations, which may be overlooked due to life-threatening acute respiratory complications. The common occurrence of neurological manifestations in outpatient clinics is important to recognize as being related to COVID-19 to initiate early intervention and prevent community spread. Altered mental status may be the presenting symptom of COVID-19, particularly in patients with pre-existing dementia. 

Neurological manifestations of hospital patients with Coronavirus disease 2019 in Wuhan, China

Neurological features in severe SARS-CoV-2 infection

Neurologic manifestations in hospitalized patients with COVID-19: the ALBA-COVID Registry

Ethical standard statement Study is in compliance with ethical standards.